Robert Avery, MD, Michael Singer, MD, Christina Weng, MD, and Paul Hahn, MD, PhD, participate in these expert roundtable talks moderated by Ivan Suñer, MD. The discussions focus on clinical outcomes with VABYSMO and examine patient groups most suitable for treatment.
Rishi Singh, MD, Caroline Baumal, MD, and David Eichenbaum, MD, present clinical data and join a panel discussion where they share advice and their own real-world experience with this innovative bispecific molecule.
VABYSMO [package insert]. South San Francisco, CA: Genentech, Inc; 2022.
VABYSMO [package insert]. South San Francisco, CA: Genentech, Inc; 2022.
Beovu® (brolucizumab) [package insert]. East Hanover, NJ: Novartis; 2020.
Beovu® (brolucizumab) [package insert]. East Hanover, NJ: Novartis; 2020.
Eylea® (aflibercept) [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc; 2021.
Eylea® (aflibercept) [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc; 2021.
LUCENTIS® (ranibizumab) [package insert]. South San Francisco, CA: Genentech, Inc; 2018.
LUCENTIS® (ranibizumab) [package insert]. South San Francisco, CA: Genentech, Inc; 2018.
SUSVIMO™ (ranibizumab injection) [package insert]. South San Francisco, CA: Genentech, Inc; 2022.
SUSVIMO™ (ranibizumab injection) [package insert]. South San Francisco, CA: Genentech, Inc; 2022.
Saharinen P, et al. Nat Rev Drug Discov. 2017;16:635-661.
Saharinen P, et al. Nat Rev Drug Discov. 2017;16:635-661.
Fiedler U, et al. Trends Immunol. 2006;27:552-558.
Fiedler U, et al. Trends Immunol. 2006;27:552-558.
Mueller SB, et al. J Clin Invest. 2016;126:3188-3191.
Mueller SB, et al. J Clin Invest. 2016;126:3188-3191.
Hakanpaa L, et al. Nat Commun. 2015;6:5962.
Hakanpaa L, et al. Nat Commun. 2015;6:5962.
Wykoff C, et al. Lancet. Published online January 24, 2022. doi:10.1016/S0140-6736(22)00018-6
Wykoff C, et al. Lancet. Published online January 24, 2022. doi:10.1016/S0140-6736(22)00018-6
Heier J, et al. Lancet. Published online January 24, 2022. doi:10.1016/S0140-6736(22)00010-1
Heier J, et al. Lancet. Published online January 24, 2022. doi:10.1016/S0140-6736(22)00010-1
Data on file. South San Francisco, CA: Genentech, Inc.
Data on file. South San Francisco, CA: Genentech, Inc.
Khanani AM, et al. JAMA Ophthalmol. 2020;138(9):964-972.
Khanani AM, et al. JAMA Ophthalmol. 2020;138(9):964-972.
Sahni J, et al. Ophthalmology. 2019;126(8):1155-1170.
Sahni J, et al. Ophthalmology. 2019;126(8):1155-1170.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.